Skip to Main Content
TABLE 3

Adjusted HRs (95% CI) for incident HF according to fasting glucose categories

Models*Categories of fasting glucose, range (mmol/l)
trend P
<5.05.0–5.55.6–6.06.1–6.9
Model 1      
    No. of cases/subjects 67/977 238/3,864 301/3,949 219/2,076  
    HR (95% CI) 1.27 (0.97–1.66) Reference 1.13 (0.95–1.34) 1.49 (1.23–1.79) 0.001 
Model 2      
    No. of cases/subjects 64/942 221/3,728 280/3,789 204/1,964  
    HR (95% CI) 1.51 (1.14–2.00) Reference 1.04 (0.87–1.24) 1.19 (0.98–1.45) 0.743 
Model 3      
    No. of cases/subjects 64/942 221/3,728 280/3,789 204/1,964  
    HR (95% CI) 1.54 (1.16–2.04) Reference 1.00 (0.84–1.20) 1.11 (0.90–1.35) 0.609 
Models*Categories of fasting glucose, range (mmol/l)
trend P
<5.05.0–5.55.6–6.06.1–6.9
Model 1      
    No. of cases/subjects 67/977 238/3,864 301/3,949 219/2,076  
    HR (95% CI) 1.27 (0.97–1.66) Reference 1.13 (0.95–1.34) 1.49 (1.23–1.79) 0.001 
Model 2      
    No. of cases/subjects 64/942 221/3,728 280/3,789 204/1,964  
    HR (95% CI) 1.51 (1.14–2.00) Reference 1.04 (0.87–1.24) 1.19 (0.98–1.45) 0.743 
Model 3      
    No. of cases/subjects 64/942 221/3,728 280/3,789 204/1,964  
    HR (95% CI) 1.54 (1.16–2.04) Reference 1.00 (0.84–1.20) 1.11 (0.90–1.35) 0.609 

*Model 1: adjusted for age, race, and sex. Model 2: model 1 + level of education, carotid atherosclerosis, systolic blood pressure, antihypertensive medication, smoking, alcohol intake, BMI, LDL-C, HDL-C, a history of CHD at baseline, and eGFR. Model 3: model 2 + A1C.

†Participants with all variables used in model 2.

Close Modal

or Create an Account

Close Modal
Close Modal